RTOG 0913: A phase I study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. Article

Chinnaiyan, Prakash, Won, Minhee, Wen, Patrick Y et al. (2013). RTOG 0913: A phase I study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. . JOURNAL OF CLINICAL ONCOLOGY, 31(15_suppl), 2047-2047. 10.1200/jco.2013.31.15_suppl.2047

cited authors

  • Chinnaiyan, Prakash; Won, Minhee; Wen, Patrick Y; Rojiani, Amyn; Wendland, Merideth M; DiPetrillo, Thomas A; Corn, Benjamin W; Mehta, Minesh P

authors

publication date

  • May 20, 2013

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Pain Research
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 2047

end page

  • 2047

volume

  • 31

issue

  • 15_suppl